Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12605000631606
ACTRN12605000631606
Completed
Not Applicable

A Multicentre Randomised Controlled Trial of Treatment of Acute Exacerbations of Asthma in Children with a Doubling of the Usual Inhaled Corticosteroid(ICS) Dose to identify efficacy of intervention.

Asthma Foundation Queensland0 sites250 target enrollmentOctober 12, 2005
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsAsthmaRespiratory - Asthma

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Asthma
Sponsor
Asthma Foundation Queensland
Enrollment
250
Status
Completed
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 12, 2005
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Asthma Foundation Queensland

Eligibility Criteria

Inclusion Criteria

  • •Currently using 125mcg or greater of inhaled Cortico\-steroid dailyExacerbation of asthma in past 12/12 requiring Oral Steroid

Exclusion Criteria

  • •Children with other respiratory diseases such as cystic fibrosis. Children with other significant medical conditions that may affect growth.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A Multicenter Randomized Controlled Clinical Trial of Acupuncture in Patients with Insomnia Dependent on Benzodiazepines
ITMCTR2200006778Fu Xing Hospital,Capital Medical University
Not yet recruiting
Not Applicable
A Multicenter Randomized Controlled Clinical Trial of Electro-acupuncture in Patients with Metabolic Associated Fatty Liver DiseaseMetabolic Associated Fatty Liver Disease
ITMCTR2200006043Beijing Friendship Hospital, Capital Medical University
Active, not recruiting
Phase 3
A randomised controlled multicentre trial of imiquimod versus radiotherapy for lentigo maligna (LM) when staged surgical excision with 5mm margins is not possible, is refused, or fails.entigo maligna (LM)Lentigo maligna (LM)Cancer - Non melanoma skin cancer
ACTRN12615000266561Melanoma and Skin Cancer (MASC) Trials126
Active, not recruiting
Not Applicable
A randomised controlled multicenter trial assessing the efficacy and safety of mesalazine therapy in patients with irritable bowel syndrome. - ND
EUCTR2007-003280-41-ITSOFAR SPA
Completed
Phase 3
Multicenter Randomized Controlled Trial to Assess the Necessity of Second-look Endoscopy after Endoscopic Submucosal Dissection (ESD) for gastric neoplasms: the SAFE studyearly gastric cancer/gastric adenoma
JPRN-UMIN000007170Graduate School of Medicine, University of Tokyo250